Early administration of ubrogepant was associated with a significant improvement in migraine symptoms compared with placebo.

Researchers found that patients with obesity had an average weight loss of 12.9% with semaglutide vs 5.6% with liraglutide ...

Vitamin D is linked to a 34% reduction in the relative risk for disease activity in patients with clinically isolated ...

"We observed in this cohort study that BMI outside of the normal category in women and men was associated with lower ...